↓
JAVASCRIPT IS DISABLED. Please enable JavaScript on your browser to best view this site.
Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from academia to industry, the evolution of molecular marker testing, and the potential for EQRx to break the impasse of escalating cancer drug costs. (42:53)
Audio Podcast
June 29, 2021 by BeaconMedIC
Posted in Beyond the Journal Podcast
Tagged Abramson Cancer Center , AccessHope , aumolertinib , Beacon Medical Interchange , BeaconMedIC , Beyond the Journal , BTJ , Cancer , cancer drug pricing , City of Hope Comprehensive Cancer Center , Dr. Charu Aggarwal , Dr. Howard (Jack) West , Education , EQRx , Foundation Medicine , Health , Leslye M Heisler Associate Professor of Medicine , Medicine , Memorial Sloan-Kettering Cancer Center , molecular marker testing , MSKCC , Oncology , Science , testing barriers , transition to industry , University of Pennsylvania School of Medicine , Vince Miller , Vincent Miller
Copyright © now=new Date;theYear=now.getFullYear();document.write(theYear) Beacon Medical Interchange – All Rights Reserved | WordPress Design by Mark Lindsey – CCWD
↑
